In 2024, Glenmark Pharmaceuticals disclosed key data related to its energy management practices, providing transparency into its operational energy use in line with recognized sustainability reporting frameworks.
Glenmark Pharmaceuticals disclosed progress toward renewable energy adoption, highlighting the share of total energy sourced from renewable versus non-renewable sources.
Finally, Glenmark Pharmaceuticals also reported the types of energy sources as well as generation technologies, helping stakeholders evaluate Glenmark Pharmaceuticals's reliance on fossil fuels versus cleaner alternatives.
Metric (GJ) | 2024 | 2023 | 2022 | 2021 - 2017 |
---|---|---|---|---|
Total Energy Consumed | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Renewable Energy Consumed | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Non-renewable Energy Consumed | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Electricity Consumed | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected energy data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
In 2024, Glenmark Pharmaceuticals consumed a total of 514,462 Gigajoules of energy across its operations. Of this total, 5.33% was sourced from renewable energy, either derived from natural resources like biofuels, biomass, or biogas, or generated using renewable technologies such as solar or wind power. The remaining 94.67% was classified as non-renewable energy, coming from fossil-based fuels such as coal, natural gas, or crude oil, or from non-renewable generation technologies like nuclear power.
In 2024, Glenmark Pharmaceuticals consumed a total of 514,462 Gigajoules of energy, of which 5.33% was derived from renewable sources, including biofuels, biomass, biogas, solar, and wind power.
This low level of renewable energy use highlights a heavy reliance on fossil fuels or other non-renewable sources, suggesting that Glenmark Pharmaceuticals has considerable room to improve its energy sustainability strategy.
Since 2021, Glenmark Pharmaceuticals's total energy consumption increased by 12.32%, including a 3.72% increase in 2024, reflecting a sustained rise in overall energy demand.
Over the same period, the share of renewable energy increased by 10.36%, but declined by 11.4% in 2024, suggesting recent volatility or sourcing constraints.
Overall, Glenmark Pharmaceuticals’s energy trends reveal a complex picture, with variations in total consumption and renewable sourcing. A closer examination of operational drivers and sourcing strategies is needed to fully assess the company’s environmental impact.
In 2024, Glenmark Pharmaceuticals disclosed detailed information on the sources and generation technologies of the energy it consumed. This disclosure enables a clearer assessment of the Glenmark Pharmaceuticals's overall energy mix, its sourcing strategy, and its reliance on fossil fuels versus cleaner alternatives such as renewables and low-carbon technologies.
In 2024, Glenmark Pharmaceuticals's total energy consumption was primarily sourced from
In 2024, Glenmark Pharmaceuticals consumed energy from 3 different sources or generation technologies, indicating a moderately diverse energy mix, with some concentration in a primary source.